Laurus Labs Q2 net profit surges on 33% rise in revenue
Laurus is executing a transformation strategy and operationalised its first commercial scale peptide plant in Visakhapatnam to address surging demand for peptide therapeutics.
Read the full story on The Hindu Opens thehindu.com in a new tab
Advertisement
Tech RajeshwarNeed a new website?Websites & apps built for your business — contact Tech RajeshwarContact us
This is a short summary of a story published by The Hindu, shown with a link to the original. The full story, photo and reporting belong to The Hindu.











